Cargando…

Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients

SIMPLE SUMMARY: In our research, we analyzed the CT scans of 322 advanced lung cancer patients over time to see how long they might remain disease-free after undergoing a specific treatment called EGFR-TKI. By integrating the patterns from these scans with other medical data, such as gene mutations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ting-Wei, Chao, Heng-Sheng, Chiu, Hwa-Yen, Lin, Yi-Hui, Chen, Hung-Chun, Lu, Chia-Feng, Liao, Chien-Yi, Lee, Yen, Shiao, Tsu-Hui, Chen, Yuh-Min, Huang, Jing-Wen, Wu, Yu-Te
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647242/ https://www.ncbi.nlm.nih.gov/pubmed/37958300 http://dx.doi.org/10.3390/cancers15215125

Ejemplares similares

A radiomics-based deep learning approach to predict progression free-survival after tyrosine kinase inhibitor therapy in non-small cell lung cancer
por: Lu, Chia-Feng, et al.
Publicado: (2023)

Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors
por: Wang, Ting-Wei, et al.
Publicado: (2023)

Application of Radiomics in Prognosing Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis
por: Wang, Ting-Wei, et al.
Publicado: (2023)

Artificial Intelligence for Early Detection of Chest Nodules in X-ray Images
por: Chiu, Hwa-Yen, et al.
Publicado: (2022)

The efficacy of first-line tyrosine kinase inhibitors combined with co-medications in Asian patients with EGFR mutation non-small cell lung cancer
por: Su, Vincent Yi-Fong, et al.
Publicado: (2020)

NEAP/DUSP26 suppresses receptor tyrosine kinases and regulates neuronal development in zebrafish
por: Yang, Chi-Hwa, et al.
Publicado: (2017)

A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma
por: Chen, Chieh-Lung, et al.
Publicado: (2023)

Clinical Characteristics of Rapid Eye Movement-Related Obstructive Sleep Apnea: An Experience in a Tertiary Medical Center of Taiwan
por: Chiu, Hwa-Yen, et al.
Publicado: (2022)

Anchor-based classification and type-C inhibitors for tyrosine kinases
por: Hsu, Kai-Cheng, et al.
Publicado: (2015)

Obstructive sleep apnea in young Asian adults with sleep-related complaints
por: Chiu, Hwa-Yen, et al.
Publicado: (2022)

Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancer
por: Shen, Chia-I, et al.
Publicado: (2021)

The association between tyrosine kinase inhibitors and fatal arrhythmia in patients with non-small cell lung cancer in Taiwan
por: Chang, Wei-Ting, et al.
Publicado: (2023)

Assessment of Tyrosine Kinase Inhibitors and Survival and Cardiovascular Outcomes of Patients With Non–Small Cell Lung Cancer in Taiwan
por: Chang, Wei-Ting, et al.
Publicado: (2023)

Comparison of the effects of the three major tyrosine kinase inhibitors as first-line therapy for non-small-cell lung cancer harboring epidermal growth factor receptor mutations
por: Tu, Chih-Yen, et al.
Publicado: (2018)

Application of Artificial Intelligence in Lung Cancer
por: Chiu, Hwa-Yen, et al.
Publicado: (2022)

Delta Radiomics Model Predicts Lesion-Level Responses to Tyrosine Kinase Inhibitors in Patients with Advanced Renal Cell Carcinoma: A Preliminary Result
por: Chen, Yuntian, et al.
Publicado: (2023)

Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma
por: Chen, Hung-Jen, et al.
Publicado: (2020)

Utilizing proteomic approach to identify nuclear translocation related serine kinase phosphorylation site of GNMT as downstream effector for benzo[a]pyrene
por: Yang, Ming-Hui, et al.
Publicado: (2019)

Improved survival in patients with unresectable stage III EGFR ‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors
por: Wang, Sheng‐Yuan, et al.
Publicado: (2021)

Overview of coronavirus disease 2019: Treatment updates and advances
por: Luo, Yung-Hung, et al.
Publicado: (2020)

Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancer
por: Shen, Chia-I, et al.
Publicado: (2022)

The Role of Tyrosine Phosphorylation of Protein Kinase C Delta in Infection and Inflammation
por: Yang, Qingliang, et al.
Publicado: (2019)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
por: Masbuchin, Ainun Nizar, et al.
Publicado: (2022)

Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis
por: Chen, Jin-Shuen, et al.
Publicado: (2014)

Clinical-radiomic model in advanced kidney cancer predicts response to tyrosine kinase inhibitors
por: Negreros-Osuna, Adrián A., et al.
Publicado: (2022)

Artificial Intelligence Assisted Computational Tomographic Detection of Lung Nodules for Prognostic Cancer Examination: A Large-Scale Clinical Trial
por: Chao, Heng-Sheng, et al.
Publicado: (2023)

Differential Inhibitory Actions of Multitargeted Tyrosine Kinase Inhibitors on Different Ionic Current Types in Cardiomyocytes
por: Chang, Wei-Ting, et al.
Publicado: (2020)

Tyrosine Sulfation as a Protein Post-Translational Modification
por: Yang, Yuh-Shyong, et al.
Publicado: (2015)

Old age and EGFR mutation status in inoperable early‐stage non‐small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 patients in Taiwan
por: Wu, Yuan‐Hung, et al.
Publicado: (2023)

Predicting pathological complete response in rectal cancer after chemoradiotherapy with a random forest using (18)F-fluorodeoxyglucose positron emission tomography and computed tomography radiomics
por: Shen, Wei-Chih, et al.
Publicado: (2020)

Comparison of Conventional and Radiomic Features between (18)F-FBPA PET/CT and PET/MR
por: Liao, Chien-Yi, et al.
Publicado: (2021)

Combination of clinical, radiomic, and “delta” radiomic features in survival prediction of metastatic gastroesophageal adenocarcinoma
por: Krishna, Satheesh, et al.
Publicado: (2023)

Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor Therapy
por: Weng, Qiaoyou, et al.
Publicado: (2021)

Radiomic features analysis in computed tomography images of lung nodule classification
por: Chen, Chia-Hung, et al.
Publicado: (2018)

Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan
por: Chien, Hung-Yu, et al.
Publicado: (2016)

Association of EGFR Tyrosine Kinase Inhibitor Treatment With Progression-Free Survival Among Taiwanese Patients With Advanced Lung Adenocarcinoma and EGFR Mutation
por: Chen, Po-Yen, et al.
Publicado: (2021)

Delta Opioid activation of the Mitogen-activated protein kinase cascade does not require transphosphorylation of Receptor Tyrosine Kinases
por: Kramer, H Kenneth, et al.
Publicado: (2002)

Delta radiomics analysis for prediction of intermediary- and high-risk factors for patients with locally advanced cervical cancer receiving neoadjuvant therapy
por: Wu, Rong-Rong, et al.
Publicado: (2023)

Enhancement of Radiosurgical Treatment Outcome Prediction Using MRI Radiomics in Patients with Non-Small Cell Lung Cancer Brain Metastases
por: Liao, Chien-Yi, et al.
Publicado: (2021)

EZH2/hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression
por: Lin, Zong-Shin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9vjoqh0mnk2fb9ar6avietd9f6